Study of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) Treatment

Stopped We observed \>90 % efficacy in cyclophosphamide and Prednisolone group for treatment of anti-i-HuEpo associated PRCA

Conditions

• Anti-r-HuEpo Associated PRCA Subjects

Interventions

• DRUG: Cyclosporine combine with mycophenolate mofetil
• DRUG: Cyclophosphamide + pred

Sponsor

Chulalongkorn University